Petit C, Saillard C, Mohty B, Hicheri Y, et al. Azacitidine-venetoclax versus azacitidine salvage treatment for primary induction failure or first relapsed acute myeloid leukaemia patients. Eur J Haematol 2024;112:530-537.
PMID: 38031389